Asia · Markets & Finance · Moneycontrol

FSSAI issues notices to Dr Reddy's, Nestle Health Science, Amazon, Flipkart over Celevida GLP+ Claims

Published by Moneycontrol · India 13 h ago

According to the regulator, such wording could suggest that the product was intended for a specific physiological condition.

Read the full article on Moneycontrol Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.moneycontrol.com)

Also worth reading

SoftBank, Grab explore AI infrastructure in Sarawak

The Straits Times Business

OpenAI’s annualised revenue US$20 billion less than previously signalled: Report

Infosys, Wipro, HCLTech, other IT shares in focus owing to multiple factors today; Details here

ROI-Five charts sounding the alarm for stretched US markets: McGeever

Hong Kong’s AI Marketing Moment is Here. The Question is Whether Business Leaders are Moving Fast Enough

The Business Times

Family offices see more tailored products, leverage ‘collective firepower’ for direct deal access